Project cooperationUpdated on 21 January 2026
Urological Oncology and Tuberous Sclerosis Disease – Search for New Therapeutic Targets
International Projects Manager INiBICA at INiBICA – Institute for Biomedical Research of Cádiz
Cadiz, Spain
About
Line 1: Metastatic Castration‑Resistant Prostate Cancer (mCRPC) and urological tumors (kidney and bladder): study of the genetics and cell biology of the disease to identify new treatments targeting the process of ciliogenesis and the structure of the Primary Cilium.
Line 2: Identification of early detection biomarkers.
Line 3: Ciliopathies: application of advanced imaging tools to identify therapies for Leber Congenital Amaurosis (LCA) and other ciliopathies caused by mutations in the CEP290 gene.
Line 4: Tuberous Sclerosis (TS): use of next‑generation massive sequencing and advanced imaging techniques to identify new therapeutic targets that suppress the renal defects associated with TS.
Topic
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
- HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
- HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
Type
- Offering Expertise to Consortias
Similar opportunities
Project cooperation
PanGI Landmark Graph™ – Whole-Tract Capsule Intelligence
- Offering Expertise to Consortias
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
- HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
- HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
Miadreza Shafiekhah
Head of Research and Innovation at Nowocert
Dublin, Ireland
Project cooperation
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
Cecilia Chinellato
EU Funds consultant at RESOLVE Srl SB
Padova, Italy
Project cooperation
CortexView Imaging Intelligence™ – AI-Enhanced Acquisition and Diagnosis
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
- HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
- HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
Miadreza Shafiekhah
Head of Research and Innovation at Nowocert
Dublin, Ireland